BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25251201)

  • 1. A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependence.
    Pettinati HM; Kampman KM; Lynch KG; Dundon WD; Mahoney EM; Wierzbicki MR; O'Brien CP
    Am J Addict; 2014; 23(6):591-7. PubMed ID: 25251201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.
    Ling W; Hillhouse MP; Saxon AJ; Mooney LJ; Thomas CM; Ang A; Matthews AG; Hasson A; Annon J; Sparenborg S; Liu DS; McCormack J; Church S; Swafford W; Drexler K; Schuman C; Ross S; Wiest K; Korthuis PT; Lawson W; Brigham GS; Knox PC; Dawes M; Rotrosen J
    Addiction; 2016 Aug; 111(8):1416-27. PubMed ID: 26948856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy.
    Schmitz JM; Stotts AL; Sayre SL; DeLaune KA; Grabowski J
    Am J Addict; 2004; 13(4):333-41. PubMed ID: 15370932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence.
    Pettinati HM; Kampman KM; Lynch KG; Suh JJ; Dackis CA; Oslin DW; O'Brien CP
    J Subst Abuse Treat; 2008 Jun; 34(4):378-90. PubMed ID: 17664051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.
    Garbutt JC; Kranzler HR; O'Malley SS; Gastfriend DR; Pettinati HM; Silverman BL; Loewy JW; Ehrich EW;
    JAMA; 2005 Apr; 293(13):1617-25. PubMed ID: 15811981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of naltrexone on alcohol and cocaine use in dually addicted patients.
    Oslin DW; Pettinati HM; Volpicelli JR; Wolf AL; Kampman KM; O'Brien CP
    J Subst Abuse Treat; 1999 Mar; 16(2):163-7. PubMed ID: 10023615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence.
    Pettinati HM; Kampman KM; Lynch KG; Xie H; Dackis C; Rabinowitz AR; O'Brien CP
    Addict Behav; 2008 May; 33(5):651-67. PubMed ID: 18079068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-release naltrexone for treatment of alcohol dependence in primary care.
    Lee JD; Grossman E; DiRocco D; Truncali A; Hanley K; Stevens D; Rotrosen J; Gourevitch MN
    J Subst Abuse Treat; 2010 Jul; 39(1):14-21. PubMed ID: 20363090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.
    Anton RF; Moak DH; Waid LR; Latham PK; Malcolm RJ; Dias JK
    Am J Psychiatry; 1999 Nov; 156(11):1758-64. PubMed ID: 10553740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term efficacy of Disulfiram or Naltrexone in reducing positive urinalysis for both cocaine and cocaethylene in cocaine abusers: a pilot study.
    Grassi MC; Cioce AM; Giudici FD; Antonilli L; Nencini P
    Pharmacol Res; 2007 Feb; 55(2):117-21. PubMed ID: 17174102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.
    Krupitsky E; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Silverman BL
    Lancet; 2011 Apr; 377(9776):1506-13. PubMed ID: 21529928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
    O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
    Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
    Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
    JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients.
    Guardia J; Roncero C; Galan J; Gonzalvo B; Burguete T; Casas M
    Addict Behav; 2011 Mar; 36(3):265-9. PubMed ID: 21146937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone and disulfiram in patients with alcohol dependence and current depression.
    Petrakis I; Ralevski E; Nich C; Levinson C; Carroll K; Poling J; Rounsaville B;
    J Clin Psychopharmacol; 2007 Apr; 27(2):160-5. PubMed ID: 17414239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial.
    Everly JJ; DeFulio A; Koffarnus MN; Leoutsakos JM; Donlin WD; Aklin WM; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
    Addiction; 2011 Jul; 106(7):1309-18. PubMed ID: 21320227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of naltrexone in the treatment of alcohol dependence: oral versus injectable delivery.
    Roozen HG; de Waart R; van den Brink W
    Eur Addict Res; 2007; 13(4):201-6. PubMed ID: 17851241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial.
    Foa EB; Yusko DA; McLean CP; Suvak MK; Bux DA; Oslin D; O'Brien CP; Imms P; Riggs DS; Volpicelli J
    JAMA; 2013 Aug; 310(5):488-95. PubMed ID: 23925619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-release naltrexone and harm reduction counseling for chronically homeless people with alcohol dependence.
    Collins SE; Duncan MH; Smart BF; Saxon AJ; Malone DK; Jackson TR; Ries RK
    Subst Abus; 2015; 36(1):21-33. PubMed ID: 24779575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.